rawfin.tv
Invivyd Shares Drop After Delaying COVID Drug Trial Data
MarketsstocksAI Generated

Invivyd Shares Drop After Delaying COVID Drug Trial Data

By rawfin.tv Markets Desk||Updated |1 min read|AI-assisted · Methodology

Invivyd (IVVD) shares fell over 13% following the company's announcement of a delay. The delay impacts the timeline for a pivotal trial of its COVID-19 drug.

invivydbiopharmaclinical-trialscovid-drugstocks

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks